Canon Medical Systems’ Premium Ultrasound Provides New and Unique Features for a Wide Range of Liver Analysis

Northwell Health Ranked Nation’s Top Health System for Diversity

New York State’s largest health care provider and private employer made the list for the ninth straight year and remained in the top spot in the 2021 DiversityInc rankings for Hospitals and Health Systems.

ZAP Surgical and Swiss Neuro Radiosurgery Center Announce Imminent Installation of New Gyroscopic Radiosurgery Platform for Treating Brain Tumors

ZAP-X is also the first and only dedicated radiosurgery system to no longer require Cobalt-60 radioactive sources, thus eliminating the significant costs to license, secure and regularly replace live radioactive isotopes.

Kathy Sherwood Joins Pelvital USA, Inc. Board of Directors

Sherwood's experience, which includes a diverse group of medical product companies such as Boston Scientific, American Medical Systems, St. Jude Medical, Kinetic Concepts, Transoma Medical and Medtronic, gives her an understanding of the problems faced by both large and small companies.

A robust suite of quantitative tools to assess the spectrum of liver disease (including Steatosis, Inflammation and Cirrhosis) on Canon Medical Systems USA, Inc.’s premium AplioTM i800 ultrasound system received FDA clearance. The industry’s most comprehensive Liver Analysis Suite is available on the Aplio i800, and may be helpful in the assessment of liver diseases such as steatosis, Non-Alcoholic Fatty Liver Disease (NAFLD) and/or Non-Alcoholic Steatohepatitis (NASH), which are characterized by elevated levels of fat accumulation in the liver.

Canon Medical Systems reports the Liver Analysis Suite equips clinicians with premium diagnostic imaging tools to facilitate the analysis of Fatty Liver Disease. In addition to Shear Wave Elastography imaging, the new suite adds Attenuation Imaging (ATI) and Shear Wave Dispersion (SWD), two exclusive features that allow health care providers to visualize and quantify tissue attenuation and dispersion slope, which is a property related to tissue viscosity, for a more comprehensive evaluation of the liver.

In addition to the Liver Analysis Suite, a wider range of transducers, available on the Aplio i-series platform, have also been granted FDA clearance. On top of the ultra-high frequency transducer (24 MHz), the Aplio i-series now includes a new 22 MHz hockey stick to visualize small and narrow areas such as fingers and joints or for interoperative procedures, as well as several new transducers for abdominal 3D, OB 4D, neonatal and vascular imaging.

Regarding viral and fatty liver disease on the rise, Dan Skyba, director, Ultrasound Business Unit, Canon Medical Systems USA, Inc. said, “The incidence of both viral and fatty liver disease is growing rapidly*, and the impact of liver disease, at every stage, is highly significant in the United States.  He concluded, “Canon is committed to new, non-invasive imaging technologies that put innovative tools in the hands of clinicians so that they can assess liver diseases earlier which may help improve a patient’s quality of life.”

* Source

 

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles